Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

External Control, preScreening, and naTurAl hiStory of Advanced retInal Degeneration Due to Rod-cone Dystrophy (ECSTASI)

NCT07854899 is registered in ClinicalTrials.gov with SparingVision as lead sponsor.

NCT NCT07854899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
External Control, preScreening, and naTurAl hiStory of Advanced retInal Degeneration Due to Rod-cone Dystrophy (ECSTASI)
Lead sponsor
SparingVision
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2026
Completion date
September 30, 2028
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rod cone dystrophy